Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Avatrombopag (a novel analog of eltrombopag), which has shown efficacy in preliminary studies on thrombocytopenia associated with liver disease (Terrault 2012), is being tested in chronic immune thrombocytopenia patients (ClinicalTrials.gov 2012b)
Author C.T
In parallel, we analyzed transcriptomic changes in the -oxidation pathway, a major route for fatty acid utilization in ILC2s ( Supplementary Figures 6A, B )
Exhaustiveness values of 8 were used for each docking simulation, reported binding affinities and displayed poses are the top-ranked position returned by PyRx
2013;16(6):E70514
US$ 22.79
US$ 21.68
US$ 27.62
US$ 28.91
US$ 29.55
US$ 22.53
US$ 26.83
